Industrial and Academic Neglected Disease Drug Discovery Collaborations – GSK and Northeastern University – CDD Webinar Video
July 5, 2017
We’re delighted to share the video and slide deck from our recent webinar featuring Dr. Julio Martin (GSK) and Dr. Michael Pollastri (Northeastern University):
Julio Martin and his colleagues at the Tres Cantos GSK Open Laboratory are working collaboratively on diseases like African Sleeping Sickness, Chagas Disease, Leishmaniasis, Tuberculosis, and Malaria in an industrial environment. Michael Pollastri brings big pharma experience to multi-center academic collaborations. Their experiences are relevant for both commercial and neglected disease drug discovery. They are both experimenting while pushing boundaries in new modes combining sensitive and open data.
Learn about GSK and Northeastern’s work directly together, and separately with dozens of leading researchers around the world. These unique approaches to collaboration and science suggest a more efficient paradigm that one day may become the status quo.
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities.
CDD Vault: Drug Discovery Informatics your whole project team will embrace